financetom
Business
financetom
/
Business
/
Bandhan Bank Q2 profit down 5% at Rs 920 cr
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bandhan Bank Q2 profit down 5% at Rs 920 cr
Nov 2, 2020 6:16 AM

Bandhan Bank on Monday reported 5.3 percent decline in net profit at Rs 920 crore for September quarter of the current fiscal year. The bank clocked a net profit of Rs 971.80 crore in the same period of 2019-20.

Total income grew 22 percent to Rs 2,304.90 crore in July-September 2020-21 as against Rs 1,889.30 crore in the year-ago period, Bandhan Bank said in a regulatory filing. Net interest income of the Kolkata-headquartered lender jumped 25.8 percent to Rs 1,923.1 crore during the quarter while the non-interest income grew 6.1 percent to Rs 381.8 crore.

Bandhan Bank said it has reported the highest ever quarterly profit before tax at Rs 1,233 crore during the period under review. Net Interest Margin (annualised) in the quarter fell to 8 percent against 8.2 percent in year-ago period. During the quarter, the bank took accelerated additional provision on standard advances amounting to Rs 300 crore. With this provision and the additional standard assets provision that bank is carrying in micro banking portfolio, the total additional provision in books stands at Rs 2,096 crore, it said.

The bank’s gross non-performing assets fell to 1.2 percent (Rs 874 crore) of gross advances as of September 30, 2020 as against 1.8 percent (Rs 1,064.20 crore) by the year-ago same period. Net NPAs too improved to 0.4 percent (Rs 262.50 crore) from 0.6 percent (Rs 336.90 crore).

”As the moratorium ended on 31st August 2020 coupled with robust rural performance, we have seen an all-round improvement in collection, disbursement and deposits. On deposits front, we have witnessed the best ever quarter whereas on the disbursement front, we are close to pre-COVID-19 level.”

Collections have seen a steady improvement month-on-month and is expected to reach near normal in the next 90 days. We now look forward to accelerate the business in H2FY 21,” Managing Director and CEO Chandra Shekhar Ghosh said. Total Advances grew 19.4 percent to Rs 76,614.6 crore as on September 30, 2020. Total deposits increased 34.4 percent to Rs 66,127.7 crore.

Bandhan Bank stock was trading at Rs 305.50 on BSE, up 5.62 percent from the previous close.

First Published:Nov 2, 2020 3:16 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US airlines want helicopters barred from some routes near DC airport
US airlines want helicopters barred from some routes near DC airport
Mar 3, 2025
WASHINGTON (Reuters) - A group representing U.S. airlines wants a series of safety changes after a fatal collision between an Army helicopter and American Airlines regional jet killed 67 people in January near Washington's Reagan National Airport. Airlines for America, which represents American, Delta Air Lines, United Airlines, Southwest Airlines and others, will call for permanently suspending some routes near...
Market Chatter: Disney Board Gets ISS Support One Year After Proxy Fight
Market Chatter: Disney Board Gets ISS Support One Year After Proxy Fight
Mar 3, 2025
11:01 AM EST, 03/03/2025 (MT Newswires) -- Walt Disney's ( DIS ) board nominees received the backing of Institutional Shareholders Services a year after the proxy adviser supported activist Nelson Peltz in his tussle with the company, Bloomberg reported Monday, citing ISS' recommendation. Disney's ( DIS ) annual meeting is March 20, according to the report. Disney ( DIS )...
Spectral Medical Nearing End of Tigris Trial Patient Enrollment
Spectral Medical Nearing End of Tigris Trial Patient Enrollment
Mar 3, 2025
11:02 AM EST, 03/03/2025 (MT Newswires) -- Spectral Medical ( EDTXF ) on Monday said it is nearing the end patient enrollment for its Tigris trial, a Phase 3 follow-on study evaluating Polymyxin B Hemoperfusion (PMX) in a trial of adults treated for endotoxemia and septic shock. The company said 152 patients are enrolled to date, with six patients signed...
McDonald's Unusual Options Activity
McDonald's Unusual Options Activity
Mar 3, 2025
Deep-pocketed investors have adopted a bearish approach towards McDonald's , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MCD usually suggests something big is about to happen. We gleaned this information from our observations today...
Copyright 2023-2026 - www.financetom.com All Rights Reserved